Glenmark Pharma receives tentative approval from USFDA for Clobetasol Propionate Foam
Glenmark Pharmaceuticals Inc., USA has been granted tentative approval by the United States Food & Drug Administration (USFDA) for Clobetasol Propionate Foam, 0.05% (Emulsion Formulation), a generic version of Olux-E Foam, 0.05%, of Mylan Pharmaceuticals, Inc. According to IQVIA sales data for the 12 month period ending September 2018, the Olux-E Foam, 0.05% market achieved … Read more
